European Journal of Pharmacology 1993-01-19

The non-depolarizing D-form of bromohomoibotenic acid enhances depolarizations evoked by the L-form or quisqualate.

U Madsen, B Ebert, J J Hansen, P Krogsgaard-Larsen

Index: Eur. J. Pharmacol. 230(3) , 383-6, (1993)

Full Text: HTML

Abstract

The D-enantiomer of bromohomoibotenic acid (Br-HIBO) was inactive in electrophysiological experiments when administered alone, but enhanced depolarizations evoked by L-Br-HIBO or quisqualate when co-administered with these agonists. In addition, quisqualate induced a long-lasting (> 120 min) sensitization of cortical wedge neurons to D-Br-HIBO. This latter effect of D-Br-HIBO was similar to, but significantly more potent and selective, than the earlier observed quisqualate-induced sensitization of cortical neurones to depolarization by (S)-2-amino-4-phosphonobutyric acid (L-AP4).


Related Compounds

Related Articles:

Turning behaviour and catalepsy after injection of excitatory amino acids into rat substantia nigra.

1981-05-29

[Neurosci. Lett. 23 , 337, (1981)]

Excitatory amino acid agonists. Enzymic resolution, X-ray structure, and enantioselective activities of (R)- and (S)-bromohomoibotenic acid.

1989-10-01

[J. Med. Chem. 32(10) , 2254-60, (1989)]

Structural determinants of agonist-specific kinetics at the ionotropic glutamate receptor 2.

2005-08-23

[Proc. Natl. Acad. Sci. U. S. A. 102(34) , 12053-8, (2005)]

Identification of amino acid residues in GluR1 responsible for ligand binding and desensitization.

2001-05-01

[J. Neurosci. 21(9) , 3052-62, (2001)]

4-Methylhomoibotenic acid activates a novel metabotropic glutamate receptor coupled to phosphoinositide hydrolysis.

1997-11-01

[J. Pharmacol. Exp. Ther. 283(2) , 742-9, (1997)]

More Articles...